EUVIMEDEUVIMED entdecken
Crossref

Enhanced Expression and Bioactivity of Recombinant Human Growth Hormone in Escherichia coli BL21 (DE3) via Codon Optimization

Barakat Abdulrazzaq Mutar, Azhar Ali Sekhi, Saba Salih Saihood, Hams Hussain Hashim Al-Fattli

International Journal of Medical Parasitology and Epidemiology Sciences · 29.06.2026 · 7 (2) · 84-93

DOI: 10.34172/ijmpes.6267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Parasitology and Epidemiology Sciences, online erschienen am 29.06.2026. Verfasst von Barakat Abdulrazzaq Mutar und 3 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The production of recombinant human growth hormone (hGH) in Escherichia coli faces limitations, such as codon bias, low translation efficiency, and improper protein folding. The aim of the current study was to investigate the effects of a codon-optimized hGH gene on protein expression, yield, and biological activity in vitro.

Methods

The hGH gene was codon-optimized to enhance the Codon Adaptation Index (from 0.62 to 0.91) and minimize rare codons (from 38 to 3) and GC content (from 67.4% to 53.2%), and was cloned into the pET21a(+) vector for expression in E.coli BL21(DE3). Bioactivity assays (Nb2 cell proliferation and IGF-1 induction in HepG2 cells), expression optimization, and inclusion body refolding were performed.

Results

Codon optimization increased total hGH expression by approximately twofold (245 vs. 120 mg/L). Following refolding optimization, a yield of 165 mg/L of biologically active hGH was achieved with a 94% refolding efficiency. The refolded recombinant hGH retained 96% proliferative activity in Nb2 cells and 92% IGF-1 stimulation capacity in HepG2 cells compared to the WHO international standard.

Conclusion

Overall, codon-optimizing hGH vastly improved the expression and yield of recombinant hGH proteins in E. coli. Combined with effective refolding strategies, this strategy presents a scalable and robust platform for producing human hormones at therapeutic scales, alleviating key biomanufacturing bottlenecks.

Zitieren

APA

Mutar, B. A., Sekhi, A. A., Saihood, S. S., & Al-Fattli, H. H. H. (2026). Enhanced Expression and Bioactivity of Recombinant Human Growth Hormone in Escherichia coli BL21 (DE3) via Codon Optimization. International Journal of Medical Parasitology and Epidemiology Sciences, 7(2), 84-93. https://doi.org/10.34172/ijmpes.6267

Vancouver

Mutar BA, Sekhi AA, Saihood SS, Al-Fattli HHH. Enhanced Expression and Bioactivity of Recombinant Human Growth Hormone in Escherichia coli BL21 (DE3) via Codon Optimization. International Journal of Medical Parasitology and Epidemiology Sciences. 2026;7(2):84-93. doi:10.34172/ijmpes.6267

BibTeX
@article{Mutar2026,
  author = {Mutar, Barakat Abdulrazzaq and Sekhi, Azhar Ali and Saihood, Saba Salih and Al-Fattli, Hams Hussain Hashim},
  title = {Enhanced Expression and Bioactivity of Recombinant Human Growth Hormone in Escherichia coli BL21 (DE3) via Codon Optimization},
  journal = {International Journal of Medical Parasitology and Epidemiology Sciences},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {84--93},
  doi = {10.34172/ijmpes.6267}
}
Kostenlos starten →